Location: Home
  • search
  • go
  • Relate News
  • 1/31/2019China Claims Steady Progress in Key Indicators of IP in 2018
  • 1/31/2019State Council Strengthens Performance Evaluation of Level 3 Hospitals
  • 1/31/2019Sumitomo Dainippon's Atypical Antipsychotic Latuda Approved for Schizo...
  • 1/30/2019NMPA Releases List of Reference Formulations for Generic Drug Equivale...
  • 1/30/2019Midatech Pharma Enters Share Purchase and Licence Deal with CMS to Rai...
  • 1/30/2019How a Tainted Heart Drug Made in China Slipped Past the FDA
  • 1/30/2019IQVIA: Global Pharma to Grow Slower in the Next Five Years
  • 1/29/2019Pfizer China, PICC and MediTrust Co-launched China’s First Pay-for-Pe...
  • 1/29/2019NMPA Suspends Sale and Application of Cheminova’s Imported Aerosol Pr...
  • 1/29/2019Innovent Files Chinese NDA for Its Biosimilar of Avastin (Bevacizumab)
  • 1/29/2019Zai Lab Secures Priority Review for Its ZEJULA (Niraparib) NDA in Chin...
  • 1/29/2019Boehringer Ingelheim Launches First Swine Vaccines Produced in China
  • 1/29/2019Implications on the Draft Amendment to the Drug Administration Law and...
  • 1/29/2019Lilly and 111, Inc. to Collaborate in Creating New Solutions for Pharm...
  • 1/28/2019The CDE Solicits Feedbacks on the Screening and Determination Process ...
  • 1/28/2019IQVIA's Digital Channel Survey Finds All Levels of Doctors Spend Simil...
  • 1/28/2019Advent International Makes Majority Investment in CRO Bioduro
  • 1/25/2019NHC Issues Notice on Clinical Consumption Requirements for Prevailing ...
  • 1/25/2019Recent Executive Movements
  • 1/25/2019Amgen Receives NMPA Approval for CVD Drug Repatha (evolocumab) in Chin...
  • 1/25/2019Amerigen Announces USFDA Approval for Generic Mixed Amphetamine Salts,...
  • 1/25/2019Pfizer Supports Breast Cancer PBM Program in Shanghai
  • 1/25/2019Lee's Pharma Completes Phase I Study of CVD Drug Tecarfarin in HK
  • 1/25/2019Zambon Eyes Acquisitions for Expansion in China and the U.S.
  • 1/25/2019Circassia Pharma Licenses U.S. and China Rights of AirNOvent from AIT
  • 1/24/2019Nicholas Hall Reports 6% Growth for Chinese OTC VMS Market in 2018
  • 1/24/2019IQVIA: Chinese Pharma Remain Over-dependent on MR Detailing with Minim...
  • 1/24/2019SAMR Launches New Initiate to Combat on Healthcare Irregularities
  • 1/23/2019Merck KGaA Boss Cheerleads for China on the Sidelines of Davos
  • 1/22/2019I-Mab Biopharma Gets FDA Clearance for IND of Novel CD73 Antibody TJD5
  • Page:239/720 Total number of articles:21572: [First][<<] [237] [238] [239] [240] [241] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group